Latest | F'cast | |
---|---|---|
Div Yield | 0.0% | 0.0% |
Div Cover | n/a | n/a |
Op Mrgn | -63.9% | n/a |
ROCE | n/a |
Latest | F'cast | |
---|---|---|
P/E | n/a | n/a |
PEG | n/a | n/a |
Pr/Revenue | 7.3 | n/a |
Pr/Book | 108.6 |
Latest | F'cast | |
---|---|---|
Revenue | -7.4% | n/a |
PBT | n/a | n/a |
EPS | n/a | n/a |
DPS | n/a | n/a |
Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
30-Jun-20 | 78.20 | 8.07 | 1.11p | 12.6 | 0.1 | +102% | n/a | 0.0% |
30-Jun-21 | 84.33 | 3.66 | 0.45p | 55.6 | n/a | -60% | n/a | 0.0% |
30-Jun-22 | 72.77 | (12.66) | (2.14)p | n/a | n/a | n/a | n/a | 0.0% |
30-Jun-23 | 59.59 | (41.77) | (6.43)p | n/a | n/a | n/a | n/a | 0.0% |
30-Jun-24 | 55.20 | (39.17) | (1.07)p | n/a | n/a | n/a | n/a | 0.0% |
a. Based on UK GAAP presentation of accounts - includes discontinued activities
Trading update for the year ended 30 June 2025 | 21-Jul-2025 | 07:00 | RNS |
PDMR Dealings | 11-Jul-2025 | 07:00 | RNS |
Interim Results for six months ended 31 Dec 2024 | 31-Mar-2025 | 07:00 | RNS |
Allergy drug firm hit by trials setback | 12-Jul-2007 | The Independent |
Need to Know: Global Business Briefing | 25-Mar-2006 | Times |
No deals were found in the last 28 days.
Currency | UK Pounds |
Share Price | 8.13p |
Change Today | -0.38p |
% Change | -4.41 % |
52 Week High | 8.75 |
52 Week Low | 4.25 |
Volume | 33,460 |
Shares Issued | 4,766.44m |
Market Cap | £387.27m |
RiskGrade | 268 |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income | ![]() |
---|
Growth |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
No dividends found |
Time | Volume / Share Price |
09:30 | 251 @ 7.50p |
09:30 | 2,895 @ 8.50p |
09:30 | 744 @ 8.50p |
09:29 | 2,000 @ 8.48p |
09:29 | 2,000 @ 8.48p |
You are here: research